Literature DB >> 26173102

Genetic Variants in the Wnt/β-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk.

Jeanne A Pierzynski1, Michelle A Hildebrandt1, Ashish M Kamat1, Jie Lin1, Yuanqing Ye1, Colin P N Dinney1, Xifeng Wu2.   

Abstract

PURPOSE: Genetic factors that influence bladder cancer risk remain largely unknown. Previous research has suggested that there is a strong genetic component underlying the risk of bladder cancer. The Wnt/β-catenin signaling pathway is a key modulator of cellular proliferation through its regulation of stem cell homeostasis. Furthermore, variants in the Wnt/β-catenin signaling pathway have been implicated in the development of other cancers, leading us to believe that this pathway may have a vital role in bladder cancer development.
MATERIALS AND METHODS: A total of 230 single nucleotide polymorphisms in 40 genes in the Wnt/β-catenin signaling pathway were genotyped in 803 bladder cancer cases and 803 healthy controls.
RESULTS: A total of 20 single nucleotide polymorphisms were nominally significant for risk. Individuals with 2 variants of LRP6: rs10743980 were associated with a decreased risk of bladder cancer in the recessive model in the initial analysis (OR 0.76, 95% CI 0.58-0.99, p=0.039). This was validated using the bladder genome-wide association study chip (OR 0.51, 95% CI 0.27-1.00, p=0.049 and for combined analysis p=0.007).
CONCLUSIONS: Together these findings implicate variants in the Wnt/β-catenin stem cell pathway as having a role in bladder cancer etiology.
Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Wnt signaling pathway; beta catenin; polymorphism; risk; single nucleotide; urinary bladder neoplasms

Mesh:

Substances:

Year:  2015        PMID: 26173102      PMCID: PMC5087323          DOI: 10.1016/j.juro.2015.07.032

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  28 in total

Review 1.  The Hedgehog and Wnt signalling pathways in cancer.

Authors:  J Taipale; P A Beachy
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

Authors:  Montserrat García-Closas; Núria Malats; Debra Silverman; Mustafa Dosemeci; Manolis Kogevinas; David W Hein; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Gemma Castaño-Vinyals; Meredith Yeager; Robert Welch; Stephen Chanock; Nilanjan Chatterjee; Sholom Wacholder; Claudine Samanic; Montserrat Torà; Francisco Fernández; Francisco X Real; Nathaniel Rothman
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

3.  Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.

Authors:  Hushan Yang; Jian Gu; Xin Lin; H Barton Grossman; Yuanqing Ye; Colin P Dinney; Xifeng Wu
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

4.  A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.

Authors:  Montserrat Garcia-Closas; Yuanqing Ye; Nathaniel Rothman; Jonine D Figueroa; Núria Malats; Colin P Dinney; Nilanjan Chatterjee; Ludmila Prokunina-Olsson; Zhaoming Wang; Jie Lin; Francisco X Real; Kevin B Jacobs; Dalsu Baris; Michael Thun; Immaculata De Vivo; Demetrius Albanes; Mark P Purdue; Manolis Kogevinas; Ashish M Kamat; Seth P Lerner; H Barton Grossman; Jian Gu; Xia Pu; Amy Hutchinson; Yi-Ping Fu; Laurie Burdett; Meredith Yeager; Wei Tang; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Gerald Andriole; Robert Grubb; Amanda Black; Eric J Jacobs; W Ryan Diver; Susan M Gapstur; Stephanie J Weinstein; Jarmo Virtamo; David J Hunter; Neil Caporaso; Maria Teresa Landi; Joseph F Fraumeni; Debra T Silverman; Stephen J Chanock; Xifeng Wu
Journal:  Hum Mol Genet       Date:  2011-08-08       Impact factor: 6.150

5.  Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer.

Authors:  Meng Chen; Michelle A T Hildebrandt; Jessica Clague; Ashish M Kamat; Antoni Picornell; Joshua Chang; Xiaofan Zhang; Julie Izzo; Hushan Yang; Jie Lin; Jian Gu; Stephen Chanock; Manolis Kogevinas; Nathaniel Rothman; Debra T Silverman; Montserrat Garcia-Closas; H Barton Grossman; Colin P Dinney; Núria Malats; Xifeng Wu
Journal:  Cancer Prev Res (Phila)       Date:  2010-09-21

6.  Apoptosis and APC in colorectal tumorigenesis.

Authors:  P J Morin; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 7.  Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers.

Authors:  Ying Ying; Qian Tao
Journal:  Epigenetics       Date:  2009-07-25       Impact factor: 4.528

Review 8.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

9.  A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.

Authors:  Nathaniel Rothman; Montserrat Garcia-Closas; Nilanjan Chatterjee; Nuria Malats; Xifeng Wu; Jonine D Figueroa; Francisco X Real; David Van Den Berg; Giuseppe Matullo; Dalsu Baris; Michael Thun; Lambertus A Kiemeney; Paolo Vineis; Immaculata De Vivo; Demetrius Albanes; Mark P Purdue; Thorunn Rafnar; Michelle A T Hildebrandt; Anne E Kiltie; Olivier Cussenot; Klaus Golka; Rajiv Kumar; Jack A Taylor; Jose I Mayordomo; Kevin B Jacobs; Manolis Kogevinas; Amy Hutchinson; Zhaoming Wang; Yi-Ping Fu; Ludmila Prokunina-Olsson; Laurie Burdett; Meredith Yeager; William Wheeler; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Gerald Andriole; Robert Grubb; Amanda Black; Eric J Jacobs; W Ryan Diver; Susan M Gapstur; Stephanie J Weinstein; Jarmo Virtamo; Victoria K Cortessis; Manuela Gago-Dominguez; Malcolm C Pike; Mariana C Stern; Jian-Min Yuan; David J Hunter; Monica McGrath; Colin P Dinney; Bogdan Czerniak; Meng Chen; Hushan Yang; Sita H Vermeulen; Katja K Aben; J Alfred Witjes; Remco R Makkinje; Patrick Sulem; Soren Besenbacher; Kari Stefansson; Elio Riboli; Paul Brennan; Salvatore Panico; Carmen Navarro; Naomi E Allen; H Bas Bueno-de-Mesquita; Dimitrios Trichopoulos; Neil Caporaso; Maria Teresa Landi; Federico Canzian; Borje Ljungberg; Anne Tjonneland; Francoise Clavel-Chapelon; David T Bishop; Mark T W Teo; Margaret A Knowles; Simonetta Guarrera; Silvia Polidoro; Fulvio Ricceri; Carlotta Sacerdote; Alessandra Allione; Geraldine Cancel-Tassin; Silvia Selinski; Jan G Hengstler; Holger Dietrich; Tony Fletcher; Peter Rudnai; Eugen Gurzau; Kvetoslava Koppova; Sophia C E Bolick; Ashley Godfrey; Zongli Xu; José I Sanz-Velez; María D García-Prats; Manuel Sanchez; Gabriel Valdivia; Stefano Porru; Simone Benhamou; Robert N Hoover; Joseph F Fraumeni; Debra T Silverman; Stephen J Chanock
Journal:  Nat Genet       Date:  2010-10-24       Impact factor: 38.330

10.  CSNK1E/CTNNB1 are synthetic lethal to TP53 in colorectal cancer and are markers for prognosis.

Authors:  Khong-Loon Tiong; Kuo-Ching Chang; Kun-Tu Yeh; Ting-Yuan Liu; Jia-Hong Wu; Ping-Heng Hsieh; Shu-Hui Lin; Wei-Yun Lai; Yu-Chin Hsu; Jeou-Yuan Chen; Jan-Gowth Chang; Grace S Shieh
Journal:  Neoplasia       Date:  2014-06-17       Impact factor: 5.715

View more
  21 in total

Review 1.  Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases.

Authors:  Z-M Wang; J-Q Luo; L-Y Xu; H-H Zhou; W Zhang
Journal:  Pharmacogenomics J       Date:  2017-07-11       Impact factor: 3.550

2.  Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p.

Authors:  Xiaojing Huang; Hongwen Zhu; Zemin Gao; Junzun Li; Junlong Zhuang; Yu Dong; Bing Shen; Meiqian Li; Hu Zhou; Hongqian Guo; Ruimin Huang; Jun Yan
Journal:  J Biol Chem       Date:  2018-03-16       Impact factor: 5.157

3.  Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.

Authors:  Hejia Yuan; Shengqiang Yu; Yuanshan Cui; Changping Men; Diandong Yang; Zhenli Gao; Zhe Zhu; Jitao Wu
Journal:  J Cell Mol Med       Date:  2017-06-19       Impact factor: 5.310

4.  Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinoma.

Authors:  Jingjing Yu; Yuling Huang; Lijuan Liu; Jing Wang; Jiye Yin; Lihua Huang; Shaojun Chen; Jingao Li; Hong Yuan; Guoping Yang; Wenyu Liu; Hai Wang; Qi Pei; Chengxian Guo
Journal:  Oncotarget       Date:  2016-12-13

Review 5.  The New Age of -omics in Urothelial Cancer - Re-wording Its Diagnosis and Treatment.

Authors:  Theodora Katsila; Michalis Liontos; George P Patrinos; Aristotelis Bamias; Dimitrios Kardamakis
Journal:  EBioMedicine       Date:  2018-02-02       Impact factor: 8.143

6.  MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21.

Authors:  Qingsong Zhang; Shuo Miao; Xihong Han; Chuanchang Li; Mengyang Zhang; Kai Cui; Tao Xiong; Zhong Chen; Chenghe Wang; Hua Xu
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

7.  Analysis of Important Gene Ontology Terms and Biological Pathways Related to Pancreatic Cancer.

Authors:  Hang Yin; ShaoPeng Wang; Yu-Hang Zhang; Yu-Dong Cai; Hailin Liu
Journal:  Biomed Res Int       Date:  2016-11-09       Impact factor: 3.411

8.  Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer.

Authors:  Liang Chen; Lushun Yuan; Gang Wang; Rui Cao; Jianping Peng; Bo Shu; Guofeng Qian; Xinghuan Wang; Yu Xiao
Journal:  Mol Med Rep       Date:  2017-10-04       Impact factor: 2.952

9.  MicroRNA-139-5p/Flt1/Wnt/β-catenin regulatory crosstalk modulates the progression of glioma.

Authors:  Qiong Wang; Bin Xu; Jixiang Du; Xinnv Xu; Chao Shang; Xiuyu Wang; Jinhuan Wang
Journal:  Int J Mol Med       Date:  2018-01-30       Impact factor: 4.101

10.  Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers.

Authors:  Andrea Polo; Silvia Marchese; Giuseppina De Petro; Maurizio Montella; Gennaro Ciliberto; Alfredo Budillon; Susan Costantini
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.